檢索結果 - Atkinson, V
- Showing 1 - 5 results of 5
-
1
-
2
-
3
Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study 由 Long, G. V., Atkinson, V., Ascierto, P. A., Robert, C., Hassel, J. C., Rutkowski, P., Savage, K. J., Taylor, F., Coon, C., Gilloteau, I., Dastani, H. B., Waxman, I. M., Abernethy, A. P.
出版 2016Text -
4
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy 由 Bowyer, S, Prithviraj, P, Lorigan, P, Larkin, J, McArthur, G, Atkinson, V, Millward, M, Khou, M, Diem, S, Ramanujam, S, Kong, B, Liniker, E, Guminski, A, Parente, P, Andrews, M C, Parakh, S, Cebon, J, Long, G V, Carlino, M S, Klein, O
出版 2016Text -
5
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy 由 Owen, CN, Shoushtari, AN, Chauhan, D, Palmieri, DJ, Lee, B, Rohaan, MW, Mangana, J, Atkinson, V, Zaman, F, Young, A, Hoeller, C, Hersey, P, Dummer, R, Khattak, MA, Millward, M, Patel, SP, Haydon, A, Johnson, DB, Lo, S, Blank, CU, Sandhu, S, Carlino, MS, Larkin, JMG, Menzies, AM, Long, GV
出版 2020Text